About Genesort
Genesort is a Healthcare company based in Herzliya (Israel) founded in 2013, and was acquired by AID Partners in May 2017. Molecular diagnostics for cancer and hereditary diseases are provided. Its focus areas include Life Sciences, Clinical Genomics, Sequencing Based and Precision Medicine.
Company details
Genesort was founded in 2013 in Herzliya, Israel, within the molecular diagnostics sector. Operations center on integrating genomics with personalized medicine for cancer and hereditary diseases. Genetic DNA profiles of patients are analyzed using advanced technologies, supporting physicians in identifying treatments matched to individual genetic characteristics. Diagnostic services are delivered to facilitate precise and safe therapeutic decisions.
- Headquarters Herzliya, Israel
- Stage Acquired
- SectorsHealthcare
- Website genesort.com
- Social LinkedIn Facebook
- Acquired by AID Partners (May 2017)
- InvestorsSingulariteam
& 1 more
- Acquired byAID Partners
(May 2017)
Funding Insights of Genesort
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Genesort with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2015 | Angel Round | – | – |
2 investors in total: 2 institutional.
Investors in Genesort
Genesort has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Singulariteam and AID Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage technology investments in Israel are targeted by Singulariteam. | singulariteam.com | Tel Aviv, Israel | ||
PE firm invests globally | aidpartners.com | Hong Kong, China |
Investor details for Genesort
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Genesort
3 dated milestones of Genesort across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Genesort is founded.
- Funding First funding round.
- Exit Acquired by AID Partners.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Genesort
Genesort was founded in 2013 and raised its 1st funding round 2 years after it was founded.
Genesort is headquartered in Herzliya, Israel. It is registered at Herzliya, Central District, Israel.
Genesort was founded in 2013 in Herzliya, Israel, within the molecular diagnostics sector. Operations center on integrating genomics with personalized medicine for cancer and hereditary diseases. Genetic DNA profiles of patients are analyzed using advanced technologies, supporting physicians in identifying treatments matched to individual genetic characteristics. Diagnostic services are delivered to facilitate precise and safe therapeutic decisions.
Genesort has 2 investors. Key investors include Singulariteam, and AID Partners.
Yes. Genesort was acquired by AID Partners in May 2017.